Team

Team

The Cergentis team is built up of highly-skilled scientists and management that are dedicated to developing additional TLA applications and making them available to more scientists and researchers across the globe.

Management Team
Joris Schuurmans, MSc
Chief Executive Officer
READ MORE

Chief Executive Officer

 

Joris received a Master of Science degree in Chemical Engineering from TU Delft. He previously worked for Janssen Biologics, MDxHealth, Biocartis, MyCartis and SkylineDx in various senior roles, among which COO at Biocartis and CEO at MyCartis. Joris is an experienced Life Sciences professional with an excellent track record.

 

Joris joined Cergentis in June 2020 as CEO as part of the company’s preparation for its next strategic phase, focused on accelerating the growth of Cergentis' biopharmaceutical transgenic analyses and QC business.

Erik Splinter, PhD
Chief Technology Officer
READ MORE

Chief Technology Officer

Erik Splinter has, both at the Erasmus MC and the Hubrecht Institute,  worked extensively on the development and optimisation of technologies for the analysis of 3D structures of human genomes. He has co-authored peer-reviewed publications in, among others, Genes & Development, Molecular Cell, and Nature Genetics.

 

At Cergentis, in his role as CTO, Erik is primarily responsible for the further development of the TLA technology and its various applications.

Judith Bergboer, PhD
Head of Services
READ MORE

Head of Services

 

Judith Bergboer received her PhD in human genetics and molecular biology from the Radboud University Nijmegen. She performed her post-doctoral studies at Harvard Medical School, where she generated and studied several transgenic and mutant zebrafish lines. She has co-authored in, among others, PLoS Genetics and Nature Genetics.

Marc Dijkstra, MSc
Chief Financial Officer
READ MORE

Chief Financial Officer

 

Marc Dijkstra received a Master of Science degree in Mathematics from Utrecht University and a Post Master Degree as Register Controller at VU Amsterdam. He has about 25 years of experience in various C-level roles in financial and business services industry, both as CFO and CEO. Since 2012 he is Managing Partner of Posthuma Partners, an international software and actuarial firm. Furthermore, Marc is non-executive Board Member and investor in several organizations in different sectors, private and non-private. He joined Cergentis as CFO in September 2020.

Harma Feitsma, PhD
Head of Business Development Oncology
READ MORE

Head of Business Development Oncology

 

Harma received an MSc degree in Biotechnology from Wageningen University and a PhD on genomics/oncogenetics in zebrafish from the Hubrecht Institute. Previously, she worked for almost 10 years at Philips; as senior scientist in molecular and precision diagnostics, in the development of diagnostic products in oncology and next generation sequencing. She co-authored several publications and patent applications.

 

At Cergentis, in her role as Head of Business Development Oncology, Harma is primarily responsible for the definition and development of new products using TLA in oncology research and diagnostics.

Service Team
Petra Klous, MSc
Operational & Customer Contact Manager
READ MORE

Operational & Customer Contact Manager

 

Petra has many years of practical experience working as a research technician at the Erasmus MC and as a lab manager at the Hubrecht Institute. She has worked on different research projects on the 3D organisation of the genome and contributed to the development and optimisation of new techniques. She joined Cergentis after receiving a Masters degree in Cancer Genomics and Developmental Biology from Utrecht University.

 

At Cergentis, Petra is responsible for our lab operations, customer service and technical support.

Maurijn Kessels, PhD
Service Team Technician
READ MORE

Service Team Technician

 

Maurijn received his PhD in the field of developmental biology studying vertebrate skeletogenesis at Wageningen University. He previously worked at the University of Liège where he studied pancreatic ductal adenocarcinoma through the development of zebrafish models.

 

At Cergentis, Maurijn works as part of the service projects team performing TLA.

Irina Sergeeva, PhD
Scientific Account Manager
READ MORE

Scientific Account Manager

 

Irina Sergeeva received her Ph.D. in molecular biology at the University of Amsterdam, where she studied the mechanisms of cardiac hypertrophy and repair. She generated several transgenic mouse reporter lines for in vitro and in vivo analysis, and used 4C-seq technology to study gene regulation in the heart.

Cheryl Dambrot, PhD
Scientific Account Manager
READ MORE

Scientific Account Manager

 

Cheryl Dambrot received her PhD from Leiden University with research in the field of stem cell biology, focusing on generating induced pluripotent stem cells to model cardiac disease. She performed her post-doctoral study at the Yale Stem Cell Center, where she investigated the mechanism behind mouse and human cellular reprogramming. 

 

At Cergentis, Cheryl works as part of the service projects team performing TLA and data analysis for our customers.

Elaine Wong, PhD
Project Scientist
READ MORE

Project Scientist

 

Elaine Wong studied Biomedical Sciences at Utrecht University. She received a PhD in molecular biology at the University of Amsterdam, where she studied the transcriptional pathways in the development of the heart. She developed and optimized technologies for the identification of whole-genome protein-DNA binding profiles.

 

At Cergentis, Elaine works as part of the service projects team performing TLA and data analysis for our customers.

Melinda Aprelia, BSc
Service Team Technician / Lab Manager
READ MORE

Service Team Technician / Lab Manager

 

Melinda Aprelia received her Bachelor degree in Life Sciences from HAN University of Applied Sciences in Nijmegen. She worked previously as a research technician at the UMC Utrecht and the Netherlands Cancer Institute, where she worked on several projects to understand the molecular mechanism of cell division in response to DNA damage.

Clara Esteban, PhD
Project Scientist
READ MORE

Project Scientist

 

Clara studied Biology and received her Ph.D. from the University of Barcelona analyzing Next Generation Sequencing data to identify variants in familial cancer patients. She started working at LUMC to learn cell culture and genetic engineering techniques (e.g., cloning, CRISPR/Cas9 and site directed mutagenesis), to assess the function of variants found in DNA repair genes.

 

At Cergentis, Clara is part of the Service Projects Team performing data analysis for our customers.

Andrea Conidi, PhD
Project Scientist
READ MORE

Project Scientist

 

Andrea received his PhD in Molecular Medicine from the KU Leuven (Belgium) and afterwards moved to the Department of Cell Biology of the Erasmus MC, Rotterdam. During his post-doc he focused on chromatin architecture dynamics during neuronal differentiation and identification of molecular targets in neurodevelopmental disorders mimicking rare diseases in vitro using human iPSCs.

 

At Cergentis, Andrea is part of the Service Team performing data analysis for our customers.

Sales, Marketing & BD Team
Martijn Kelder, PhD
Sales Director
READ MORE

Sales Director

 

Martijn Kelder obtained his MSc in molecular genetics from Utrecht University, after which he further specialised in the mechanisms of genome editing using CRISPR/Cas9 during his doctoral training at the University of Edinburgh. He has co-authored in several journals including PLoS Biology and Nature Protocols.

 

As Sales Director at Cergentis, Martijn leads the sales team, oversees business development and establishes long-term partnerships with key customers.

Natalia Loaiza, MSc
Sales & Account Manager
READ MORE

Sales & Account Manager

 

Natalia Loaiza was trained as a Microbiologist and Clinical Chemist at the University of Costa Rica and obtained her master’s degree in Biomedical Research from the University of Groningen. Her PhD research at the University Medical Center Groningen focused on elucidating the function of novel genes associated with cardio-metabolic diseases. She has co-authored in different peer-review journals, including Cell and ATVB.

 

As Sales and Account Manager at Cergentis, Natalia is responsible for maintaining and developing customer relationships in the area of genetically engineered models and cell line development.

Alexander Jansma, MSc
Sales & Account Manager
READ MORE

Sales & Account Manager

 

Alexander Jansma received his MSc in Biomedical Sciences & Science Based Business from the University of Leiden, after which he worked at a DNA sequencing contract service laboratory and a metagenomics microbiome company. He wrote different business cases on genomics and has an interest in precision medicine.

 

As Sales & Account Manager at Cergentis, he is responsible for managing new and existing customers in the fields of cell & gene therapy.

Nicole Hendriks, BSc
International Sales Manager
READ MORE

International Sales Manager

 

Nicole pursued a bachelor’s degree in Biology and Medical Laboratory Sciences at University of Applied Science Leiden, where she specialized in animal research. During her studies she had the chance to gain experience interning at the Oxford University in molecular biology, and interning at the Institute for Functional Genomics Montpellier in animal research.

 

As International Sales Manager at Cergentis, Nicole is responsible for maintaining and developing customer  relationships in the area of genetically engineered models.

Wietske Stevens, MSc
Marketing Director
READ MORE

Marketing Director

 

Wietske received her Bachelor Degree in International Communication Management from The Hague University of Applied Sciences and a Master of Science degree in Communication Sciences from VU Amsterdam. She started her career as content creator and editor for online magazines, and since then gained a lot of experience in both online and offline marketing communication activities as well as writing and executing strategic communication plans.

 

At Cergentis, she is responsible for all marketing & communication related activities.

Allan La, MSc
Scientific Content Marketeer
READ MORE

Scientific Content Marketeer

With a MSc in Science and Business Management from Utrecht University, Allan joined the team as an International Sales Manager to help the company tap into the Cell & Gene Therapy market. After significantly improving Cergentis' position within this field, he then headed the acquisitions of all new customers within our Genetic Engineering portfolio. 

 

In February 2021, Allan joined the Marketing department to help create strategic marketing plans, write scientific contents, and be involved in conducting post-campaign analysis to continuously improve the quality and effectiveness of our marketing communications.

Emily Caulfield, MSc
Business Development Analyst
READ MORE

Business Development Analyst

 

Emily Caulfield received her Bachelor of Science degree in Biotechnology at the University of Melbourne before attaining her Master of Science degree in Biology & Business Studies at Leiden University. During her studies, she completed early-stage research at Leiden University Medical Centre and gained business experience at a clinical-stage RNA therapy company.

 

As Business Development Analyst, Emily is responsible for defining markets, identifying key companies and leads, and monitoring market developments.

Bioinformatics Team
Mario Cangiano, MSc
Bioinformatics Scientist
READ MORE

Bioinformatics Scientist

 

Mario Cangiano received his Bachelor Degree in Biotechnology and a Master of Science in Genetics from the University of Sannio, Italy. He worked as a bioinformation at BioGeM and later as an R&D Scientist at GenomeScan, in Leiden. During his work he performed translational research for in-silico biomarker discovery and tumor classification and he has co-authored in a Nature Medicine publication.

 

At Cergentis, Mario is working on the development of bioinformatics pipelines and software for various applications of the TLA technology.

 

Georgios Georgiou, PhD
Head of Bioinformatics & Software Development
READ MORE

Head of Bioinformatics & Software Development

 

George has a background in Computing Science, Bioinformatics, and Computational Systems Biology. He received his Ph.D. in Developmental and Computational biology at the Radboud University in Nijmegen, where he studied chromatin and gene regulatory networks dynamics during early embryonic development. After his Ph.D., George worked in a CRO as a bioinformatician. Later he managed the departments of IT, Computerized Systems Validation, and Bioinformatics. He has co-authored peer-reviewed publications in, among others, Nature, Nature Communications, and Genome Biology.

 

George joined Cergentis in 2020 as the Head of Bioinformatics and Software development. He is responsible for the development of bioinformatics pipelines and software used within Cergentis and by customers and clinical collaboration partners.

Vera Boersma, PhD
Bioinformatics Scientist
READ MORE

Bioinformatics Scientist

 

After receiving her Masters degree in cancer genomics and developmental biology from the Utrecht University, Vera attended a PhD program at the NKI. During her PhD she focused on the role of DNA repair mechanisms in telomere dysfuncion. She identified a new factor involved in DNA repair of double strand breaks which led to a publication in Nature.

 

At Cergentis Vera is working as a product developer on the optimisation of the TLA technology for oncogenetic applications.

Frans-Paul Ruzius, BSc
Bioinformatician/Full-stack developer
READ MORE

Bioinformatician/Full-stack developer

 

Frans-Paul received a Bachelor's degree in Bioinformatics and started his career at the Hubrecht Institute as a Bioinformatician. After this, he joined the Software Development Team at GenDx for 8 years where he also became the System Administrator, managed the local network, email and storage while contributing to the development of commercial software.

 

At Cergentis, he is part of the Bioinformatics Team and is responsible for developing an analysis pipeline application. 

R&D Team
Max van Min, MSc
Chief Scientific Officer
READ MORE

Chief Scientific Officer


Max van Min received a Master of Science degree in Biotechnology from Wageningen University & Research Centre and has previously worked in management positions at Keygene and the life sciences multinational DSM. He is co-inventor of the TLA technology. 

Mehmet Yilmaz, BSc
Product Developer
READ MORE

Product Developer

 

Mehmet Yilmaz received a Bachelors degree in Life Sciences with a minor in Microbiology from the University of Applied Sciences in Utrecht, The Netherlands. He was one of the first technicians to join Cergentis and has worked extensively on the optimisation of the TLA protocol on both cells and isolated genomic DNA.

 

At Cergentis, Mehmet is working as a product developer on the optimisation of the TLA technology for various applications.

Joost Swennenhuis, PhD
Product Developer
READ MORE

Product Developer

 

Joost Swennenhuis received his PhD from the University of Twente with research in the field oncology and liquid biopsy, focusing on the isolation and molecular analysis of circulating tumor cells. Formerly Joost has developed products for Immunicon corp in Enschede and Kreatech biotechnology (Now Leica) in Amsterdam and has worked at Veterinary Pathology of the University of Utrecht.

 

At Cergentis, Joost is working as a product developer on the optimisation of the TLA technology for several applications.

Ellen Stelloo, PhD
Clinical Scientist
READ MORE

Clinical Scientist

 

Ellen Stelloo obtained her PhD at Leiden University. Her PhD focused on molecular classification of endometrial cancer to guide adjuvant treatment decisions. She performed her post-doctoral studies at University Medical Center Utrecht, where she generated patient-derived ovarian cancer organoids to study drug responses and used single-cell sequencing to capture the genomic consequence of chromatin errors during mitosis.

 

At Cergentis, Ellen is primarily responsible for managing clinical collaborations and execution of validation studies for oncology applications.

Christian Valdes, PhD
Product Developer
READ MORE

Product Developer

 

Christian Valdes received his PhD in Biomedical Sciences from the National Autonomous University of Mexico, where he studied the role of epigenetic mechanisms regulating gene expression. He conducted his post-doctoral research at the Hubrecht Institute focusing on the 3D organization of the genome and gene expression. He has co-authored publications in, among others, Molecular Cell and Nat Struct Mol Biol.

 

At Cergentis, Christian is working as a product developer on the optimization of the TLA technology for expanding its applications.

Quality & Finance Team
Maaike van der Weij, MSc
Quality Manager
READ MORE

Quality Manager

 

After receiving her Masters degree in Biomolecular Science from Utrecht University, Maaike worked for over 10 years in Quality roles within various biotech companies, mainly in the pharmaceutical industry. Her focus is on process performance & improvement and creating a solid Quality Management System. 

 

At Cergentis, Maaike is responsible for the design, maintenance and performance of the Quality Management System.

Bianca Reek
Administrator
READ MORE

Administrator

 

Bianca is an experienced professional in the field of administration. She started her career in 1986 at DAF Noord-Holland as a telephone operator whilst getting her Accounting Degree at the Association. Bianca has been part of Accounts Payable and Accounts Receivable teams, Contracts and Stock Administrations in both large and smaller companies. 

 

At Cergentis, Bianca is not only part of the Accounts Department as Administrator but also our "Jack of all trades" taking care of many other tasks, to the delight of rest of the team. 

Deo van Holst
Administator
READ MORE

Administrator

 

Deo van Holst has an extensive career in finance. After getting his Degree, he began his career as an Accounting Assistant, worked as an Administrator and was Financial Director for the last 22 years. 

Deo joined Cergentis as Administrator in 2021. 

© 2012-2021 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.
We use cookies for website analysis and marketing. By visiting and using our website you accept these cookies.
ACCEPT